BioBase: Feasibility Investigation of Biometry and Tomography Measurements in a Heterogeneous Patient Cohort

Sponsor
Carl Zeiss Meditec AG (Industry)
Overall Status
Not yet recruiting
CT.gov ID
NCT05458661
Collaborator
(none)
100
1
7

Study Details

Study Description

Brief Summary

The planned clinical investigation will be conducted to acquire raw data for the development of the algorithm. The data acquisition is intended to obtain first impressions of the potential performance of the changed hardware and software components and to confirm the safety profile assessed by risk analysis.

Condition or Disease Intervention/Treatment Phase
  • Device: Clinical Prototype BioBase (SN 07 and SN 08)
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
all suitable/eligible subjects will undergo a series of biometry measurementsall suitable/eligible subjects will undergo a series of biometry measurements
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Feasibility Investigation of Biometry and Tomography Measurements in a Heterogeneous Patient Cohort (BioBase)
Anticipated Study Start Date :
Aug 1, 2022
Anticipated Primary Completion Date :
Mar 1, 2023
Anticipated Study Completion Date :
Mar 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Other: recruited patient population

Device: Clinical Prototype BioBase (SN 07 and SN 08)
Scheimpflug- or OCT based corneal tomographers with the ability to measure anterior and posterior corneal curvature maps >6mm diameter and corneal pachymetry maps >6mm.
Other Names:
  • IOLMaster 700 Vs. 1.90 (Carl Zeiss Meditec AG, Göschwitzer Straße 51-52, 07745 Jena)
  • Pentacam HR (Oculus Optikgeräte GmbH, Münchholzhäuser Straße 29, 35582 Wetzlar)
  • MS-39 (bon Optic Vertriebsges. mbH, Stellmacherstraße 14, 23556 Lübeck)
  • Outcome Measures

    Primary Outcome Measures

    1. Data collection for algorithm development - Cornea to retina Scan [day 1]

      - Cornea to retina Scan (all axial measurements) The data will be used within the Carl Zeiss Meditec R&D department to further develop the algorithm of this device to get a next generation biometry device with automated base.

    2. Data collection for algorithm development - Corneal topography [day 1]

      - Corneal topography (raw data and images) including keratometry The data will then be used within the Carl Zeiss Meditec R&D department to further develop the algorithm of this device to get a next generation biometry device with automated base.

    3. Data collection for algorithm development - - Anterior-segment OCT data [day 1]

      - Anterior-segment OCT data The data will be used within the Carl Zeiss Meditec R&D department to further develop the algorithm of this device to get a next generation biometry device with automated base.

    4. Data collection for algorithm development - Extended retina-scan [day1]

      - Extended retina-scan The data will be used within the Carl Zeiss Meditec R&D department to further develop the algorithm of this device to get a next generation biometry device with automated base.

    5. Data collection for algorithm development - Reference pictures for markerless alignment of toric IOL (sclera images) [day 1]

      - Reference pictures for markerless alignment of toric IOL (sclera images) The data will be used within the Carl Zeiss Meditec R&D department to further develop the algorithm of this device to get a next generation biometry device with automated base.

    6. Data collection for algorithm development - White-to-white determination [day 1]

      - White-to-white determination The data will then be used within the Carl Zeiss Meditec R&D department to further develop the algorithm of this device to get a next generation biometry device with automated base.

    7. Data collection for algorithm development - IOL Imaging pictures [day 1]

      - IOL Imaging pictures The data will then be used within the Carl Zeiss Meditec R&D department to further develop the algorithm of this device to get a next generation biometry device with automated base.

    8. Affected measurements - OCT measurements [day 1]

      It will be investigated, whether the measurements with the study prototype device are affected by the base movement. - OCT measurements This outcome will be investigated by comparing the raw data of the study prototype device with the data measured with the marketed IOLMaster 700 and Pentacam / MS-39 devices. Non-optimal positioning and movement could possibly cause blurred images that would prevent a detailed analysis

    9. Affected measurements - Keratometry and Topography measurements [day 1]

      It will be investigated, whether the measurements with the study prototype device are affected by the base movement. - Keratometry and Topography measurements This outcome will be investigated by comparing the raw data of the study prototype device with the data measured with the marketed IOLMaster 700 and Pentacam / MS-39 devices. Non-optimal positioning and movement could possibly cause blurred images that would prevent a detailed analysis

    10. Affected measurements - - WTW measurements [day 1]

      It will be investigated, whether the measurements with the study prototype device are affected by the base movement. - WTW measurements This outcome will be investigated by comparing the raw data of the study prototype device with the data measured with the marketed IOLMaster 700 and Pentacam / MS-39 devices. Non-optimal positioning and movement could possibly cause blurred images that would prevent a detailed analysis

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    21 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Male or female 21 years of age and older

    • Able and willing to make the required study visit

    • Able and willing to provide consent and follow study instructions

    • Patients must have understood and signed the informed consent

    Exclusion Criteria:
    • Any performed contact measurements or examinations in which the eye is touched on the same day prior to the investigation measurement

    • Physical inability to be positioned at the study devices (e.g. torticollis, head tremor, injuries at forehead or chin, etc.)

    • Principal Investigator's determination that the subject is not suitable due to other medical condition (reasons to be listed on eCRF)

    • Known Pregnancy

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Carl Zeiss Meditec AG

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Carl Zeiss Meditec AG
    ClinicalTrials.gov Identifier:
    NCT05458661
    Other Study ID Numbers:
    • B2101CI
    First Posted:
    Jul 14, 2022
    Last Update Posted:
    Jul 14, 2022
    Last Verified:
    Jul 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jul 14, 2022